| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-11 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |